Image from Google Jackets

Antifungal drugs: Targeting histone acetylation

Tipo de material: TextoTextoSeries ; Nature Reviews Drug Discovery, 9, p.680-681, 2010Trabajos contenidos:
  • Harrison, Charlotte
Tema(s): Recursos en línea: Resumen: The fungal pathogen Candida albicans causes serious infections in immunocompromised individuals, and although treatment is possible using azole or echinocandin drugs, their efficacy can be compromised by the emergence of drug-resistant strains. Writing in Nature Medicine, Wurtele and colleagues show that fungal enzymes that regulate histone acetylation - specifically the acetylation of lysine 56 on histone H3 (H3K56ac)- could be new targets for the treatment of C. albicans
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Collection Call number Status Date due Barcode
Documentos solicitados Documentos solicitados CICY Documento préstamo interbibliotecario Ref1 B-15907 (Browse shelf(Opens below)) Available

The fungal pathogen Candida albicans causes serious infections in immunocompromised individuals, and although treatment is possible using azole or echinocandin drugs, their efficacy can be compromised by the emergence of drug-resistant strains. Writing in Nature Medicine, Wurtele and colleagues show that fungal enzymes that regulate histone acetylation - specifically the acetylation of lysine 56 on histone H3 (H3K56ac)- could be new targets for the treatment of C. albicans

There are no comments on this title.

to post a comment.